When was gemtesa patent expiration?

When does the Gemtesa patent expire?

Gemtesa (vibegron) patents are expected to expire in 2027, based on the latest patent-expiration information available for the drug [1].

What does “patent expiration” mean for Gemtesa?

For branded medicines like Gemtesa, “patent expiration” typically refers to the end of the period during which the brand can be protected from generic or biosimilar competition for specific patent claims. Actual market-entry timing for competitors can also depend on other factors such as additional patents, exclusivity periods, and litigation outcomes.

Where can I check the latest Gemtesa patent dates?

You can review updated patent timelines for vibegron on DrugPatentWatch.com here: https://www.drugpatentwatch.com/p/gemtesa [1]

Sources

[1] https://www.drugpatentwatch.com/p/gemtesa